Contrary to previous assumptions, nerve cells in the human neocortex are wired differently than in mice. Those are the findings of a new study conducted by Charité – Universitätsmedizin Berlin and published in the journal Science.* The study found…
Thu 23 May | 14:30 – 18:00 CEST | Nijmegen & virtual
Cortisone and other related glucocorticoids are extremely effective at curbing excessive immune reactions. But previously, astonishingly little was known about how they exactly do that. A team of researchers from Charité – Universitätsmedizin Berlin…
Düsseldorf, Tokyo and New York – April 11, 2024 – Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate…
Neuroscientists Gary Lewin and James Poulet at the Max Delbrück Center for Molecular Medicine have won highly coveted and competitive ERC Advanced Grants to study pain and the neural mechanisms that underlie temperature perception.
BIOMONITOR IV and SmartECG Enable Workflow Optimization and Personalized Treatment Decisions
The World Health Organization (WHO) has selected the Institute of Virology at Charité – Universitätsmedizin Berlin as a member of the newly established WHO Coronavirus Network (CoViNet). The global network of reference laboratories aims to detect and…
ProBioGen, a globally recognized and experienced Contract Development & Manufacturing Organization (CDMO), proudly announces a partnership with DIOSynVax Ltd to manufacture DIOS-HFVac3, a trivalent hemorrhagic fever (HF) vaccine that was developed in…
Eckert & Ziegler BEBIG GmbH, subsidiary of Eckert & Ziegler SE with focus on brachytherapy solutions for the treatment of prostate cancer as well as eye and brain tumors, obtained the MDR certificate for its proprietary prostate seeds from DEKRA…
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s precision oncology development portfolio
Co-development of a novel target…
